Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Ligand Pharmaceuticals Incorporated (LGND) had Return on Assets of 9.43% for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$30.98M |
|
$86.14M |
|
$2.88M |
|
$28.10M |
|
$27.99M |
|
$2.99M |
|
$110.46M |
|
$113.45M |
|
$2.67M |
|
$86.14M |
|
$86.14M |
|
$86.14M |
|
$-51.30M |
|
$2.99M |
|
$11.68M |
|
17.73M |
|
18.12M |
|
$4.86 |
|
$4.75 |
|
| Balance Sheet Financials | |
$368.91M |
|
$15.13M |
|
$544.96M |
|
$913.87M |
|
$17.82M |
|
-- |
|
$89.53M |
|
$107.35M |
|
$806.52M |
|
$409.85M |
|
$806.52M |
|
17.92M |
|
| Cash Flow Statement Financials | |
$18.73M |
|
$-3.77M |
|
$12.18M |
|
$22.95M |
|
$50.09M |
|
$27.14M |
|
$7.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.70 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
90.70% |
|
9.65% |
|
9.65% |
|
-- |
|
366.22% |
|
278.07% |
|
$18.63M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.14 |
|
1.09 |
|
82.61 |
|
10.68% |
|
21.02% |
|
|
Return on Assets |
9.43% |
10.68% |
|
$45.00 |
|
$1.03 |
|
$1.03 |
|